Literature DB >> 26724334

Radioligand binding to intact cells as a tool for extended drug screening in a representative physiological context.

Georges Vauquelin1, Isabelle Van Liefde2, David C Swinney3.   

Abstract

Radioligand binding assays on intact cells offer distinct advantages to those on membrane suspensions. Major pharmacological properties like drug affinity and binding kinetics are more physiologically relevant. Complex mechanisms can be studied with a wider choice of experimental approaches and so provide insights into induced-fit type binding, receptor internalisation and even into pharmacomicrokinetic phenomena like drug rebinding and partitioning into the membrane. Hence, intact cell binding constitutes a valuable addition to the pharmacologist's toolbox.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2015        PMID: 26724334     DOI: 10.1016/j.ddtec.2015.09.001

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  4 in total

Review 1.  Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo.

Authors:  Georges Vauquelin
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

Review 2.  Binding kinetics of ligands acting at GPCRs.

Authors:  David A Sykes; Leigh A Stoddart; Laura E Kilpatrick; Stephen J Hill
Journal:  Mol Cell Endocrinol       Date:  2019-02-08       Impact factor: 4.102

3.  Site-specific effects of neurosteroids on GABAA receptor activation and desensitization.

Authors:  Yusuke Sugasawa; Wayland Wl Cheng; John R Bracamontes; Zi-Wei Chen; Lei Wang; Allison L Germann; Spencer R Pierce; Thomas C Senneff; Kathiresan Krishnan; David E Reichert; Douglas F Covey; Gustav Akk; Alex S Evers
Journal:  Elife       Date:  2020-09-21       Impact factor: 8.140

4.  Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [177Lu]Lu-OPS201 Compared to the Agonist [177Lu]Lu-DOTA-TATE.

Authors:  Rosalba Mansi; Pascale Plas; Georges Vauquelin; Melpomeni Fani
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.